Induced pluripotent stem cells (iPSCs) and iPSC-derived cerebral organoids as a model of Succinic Semialdehyde Dehydrogenase Deficiency


Succinic semialdehyde dehydrogenase defi-ciency (SSADHD) represents a rare monogenetic diseasecausing disturbed degradation of γ-aminobutyric acid (GABA) due to variants in ALDH5A1. Succinic-semialdehyde cannot be oxidized to succinate and is consecutively reduced to γ-hydroxybutyrate (GHB). The phenotype is comprised of developmental delay, motor difficulties, behavioral problems, and epilepsy. It is unclear how altered concentrations of GABA and GHB contribute to the pathophysiology of SSADHD. We used patient-derived inducedpluripotent stem cells (iPSCs) to generate a three-dimensional cell culture model to study early neuronaldevelopment in SSADHD. Immunohistochemistry and whole-cell patch clamp were used to determine morphological and electrophysiological properties.

Sep 4, 2019 10:00 AM — 10:15 AM
De Doelen ICC Rotterdam, The Netherlands
Schouwburgplein 50, Rotterdam, 3012 CL
Heiko Brennenstuhl
Medical professional, board-certified pediatrician, MBA & Postdoctoral Research Fellow

I am interested in inherited monogenic disorders and specialize in stem cell research and high-throughput data analysis.